Cargando…

Defending against SARS-CoV-2: The T cell perspective

SARS-CoV-2-specific T cell response has been proven essential for viral clearance, COVID-19 outcome and long-term memory. Impaired early T cell-driven immunity leads to a severe form of the disease associated with lymphopenia, hyperinflammation and imbalanced humoral response. Analyses of acute SARS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almendro-Vázquez, Patricia, Laguna-Goya, Rocío, Paz-Artal, Estela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911802/ https://www.ncbi.nlm.nih.gov/pubmed/36776863 http://dx.doi.org/10.3389/fimmu.2023.1107803

Ejemplares similares

Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2022)

Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination
por: Horndler, Lydia, et al.
Publicado: (2023)

SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy
por: Lledó, Ana, et al.
Publicado: (2021)

Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency
por: Arroyo-Sánchez, Daniel, et al.
Publicado: (2021)

Discordance Between SARS-CoV-2–specific Cell-mediated and Antibody Responses Elicited by mRNA-1273 Vaccine in Kidney and Liver Transplant Recipients
por: Fernández-Ruiz, Mario, et al.
Publicado: (2021)

Hemodialysis-Associated Immune Dysregulation in SARS-CoV-2-Infected End-Stage Renal Disease Patients
por: González-Cuadrado, Cecilia, et al.
Publicado: (2023)

Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2021)

Immune Response Against SARS-CoV-2 Infection and Vaccination in a CD8α-Deficient Patient
por: Arroyo-Sánchez, Daniel, et al.
Publicado: (2023)

Pulmonary surfactant itself must be a strong defender against SARS-CoV-2
por: Takano, Hideyuki
Publicado: (2020)

Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5–adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients
por: Fernández-Ruiz, Mario, et al.
Publicado: (2023)

A Short Corticosteroid Course Reduces Symptoms and Immunological Alterations Underlying Long-COVID
por: Utrero-Rico, Alberto, et al.
Publicado: (2021)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)

Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination
por: Esparcia-Pinedo, Laura, et al.
Publicado: (2022)

Hold Breath: Autonomic Neural Regulation of Innate Immunity to Defend Against SARS-CoV-2 Infection
por: Wang, Changle, et al.
Publicado: (2022)

Prospects of Neutralizing Nanobodies Against SARS-CoV-2
por: Chen, Fangfang, et al.
Publicado: (2021)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Tolerogenic Role of Myeloid Suppressor Cells in Organ Transplantation
por: Ochando, Jordi, et al.
Publicado: (2019)

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters
por: Boudewijns, Robbert, et al.
Publicado: (2022)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
por: Abdelrahman, Zeinab, et al.
Publicado: (2020)

Perspective: Reducing SARS-CoV2 Infectivity and Its Associated Immunopathology
por: Dubey, Abhishek, et al.
Publicado: (2020)

Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection
por: Lin, Aifen, et al.
Publicado: (2021)

Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections
por: Kim, Byoung-Jun, et al.
Publicado: (2021)

Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
por: Vignesh, Ramachandran, et al.
Publicado: (2020)

Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants
por: Shrestha, Lok Bahadur, et al.
Publicado: (2021)

Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives
por: Zhu, Qiugang, et al.
Publicado: (2022)

Defenders and Challengers of Endothelial Barrier Function
por: Rahimi, Nader
Publicado: (2017)

The Neutrophil: Constant Defender and First Responder
por: Fine, Noah, et al.
Publicado: (2020)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
por: Liang, Yanwen, et al.
Publicado: (2020)

The Defenders of the Alveolus Succumb in COVID-19 Pneumonia to SARS-CoV-2, Necroptosis, Pyroptosis and Panoptosis
por: Schifanella, Luca, et al.
Publicado: (2022)

The Defenders of the Alveolus Succumb in COVID-19 Pneumonia to SARS-CoV-2 and Necroptosis, Pyroptosis, and PANoptosis
por: Schifanella, Luca, et al.
Publicado: (2023)

Does Angiotensin II Peak in Response to SARS-CoV-2?
por: Xavier, Léder Leal, et al.
Publicado: (2021)

Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
por: Xiao, Xia, et al.
Publicado: (2020)

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
por: Xie, Jiajia, et al.
Publicado: (2021)

BCG mediated protection of the lung against experimental SARS-CoV-2 infection
por: Hilligan, Kerry L., et al.
Publicado: (2023)

The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria
por: Kell, Douglas B., et al.
Publicado: (2020)

CD8(+) T Cells in SARS-CoV-2 Induced Disease and Cancer—Clinical Perspectives
por: Mortezaee, Keywan, et al.
Publicado: (2022)

Cannabidiol and SARS-CoV-2 Infection
por: Vallée, Alexandre
Publicado: (2022)

Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity
por: Scaglione, Antonella, et al.
Publicado: (2021)

Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses
por: Cao, Yingying, et al.
Publicado: (2021)

Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2
por: Markewitz, Robert, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jmpbecmrhtjjd8kgj1cpv8njdn